Clinical Trial Update: Ribavirin Bioavailability After Telaprevir Exposure

View source ↗

Summary

A pharmacokinetic study evaluating ribavirin bioavailability after exposure to telaprevir in patients with hepatitis C; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatitis C | Status: COMPLETED